Torrent Pharmaceuticals (NSE:TORNTPHARM) Construction In Progress: ₹4,856 Mil (As of Mar. 2026)


NSE:TORNTPHARM Torrent Pharmaceuticals Ltd NSE:TORNTPHARM
85 GF Score
Price ₹4,768.30
GF Value ₹4,321.64
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Torrent Pharmaceuticals Construction In Progress?

Torrent Pharmaceuticals NSE:TORNTPHARM +2.29% 85 Construction In Progress is ₹4,856 Mil as of Mar. 2026. GuruFocus rates NSE:TORNTPHARM with a GF Score™ of 85/100 and a GF Value™ of ₹4,321.64 (Fairly Valued). The stock has 6 warning signs investors should review.

Torrent Pharmaceuticals's quarterly construction in progress declined from Sep. 2025 (₹4,880 Mil) to Dec. 2025 (₹0 Mil) but then increased from Dec. 2025 (₹0 Mil) to Mar. 2026 (₹4,856 Mil).

Torrent Pharmaceuticals's annual construction in progress increased from Mar. 2024 (₹2,962 Mil) to Mar. 2025 (₹4,091 Mil) and increased from Mar. 2025 (₹4,091 Mil) to Mar. 2026 (₹4,856 Mil).

Torrent Pharmaceuticals Construction In Progress Historical Data

* Premium members only.

The historical data trend for Torrent Pharmaceuticals's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Torrent Pharmaceuticals Construction In Progress Chart

Torrent Pharmaceuticals Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Construction In Progress
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5,702.70 7,107.10 2,961.80 4,090.90 4,855.90

Torrent Pharmaceuticals Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4,090.90 0.00 4,880.00 0.00 4,855.90
NSE:TORNTPHARM
85GF Score
Torrent Pharmaceuticals Ltd NSE:TORNTPHARM
Construction In Progress is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Torrent Pharmaceuticals Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

What does a Construction In Progress of ₹4,856 Mil mean?
Torrent Pharmaceuticals (NSE:TORNTPHARM) has a Construction In Progress of ₹4,856 Mil as of Mar. 2026. Construction in Progress records the amount of construction work that is not complete. View historical data on Torrent Pharmaceuticals and its competitors.
Is Torrent Pharmaceuticals' Construction In Progress too high?
Torrent Pharmaceuticals' current Construction In Progress is ₹4,856 Mil. Overall, Torrent Pharmaceuticals has a GF Score™ of 85/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Torrent Pharmaceuticals' Construction In Progress compare to ZTS and UTHR?
Torrent Pharmaceuticals' Construction In Progress of ₹4,856 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Construction In Progress for a Drug Manufacturers company?
A good Construction In Progress depends on the Drug Manufacturers industry context. However, Construction In Progress should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Construction In Progress mean?
A high Construction In Progress can signal that a stock is expensive relative to its fundamentals. Construction in Progress records the amount of construction work that is not complete. View historical data on Torrent Pharmaceuticals and its competitors. Torrent Pharmaceuticals's current Construction In Progress is ₹4,856 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Torrent Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, Torrent Pharmaceuticals (NSE:TORNTPHARM) is currently considered Fairly Valued. The stock's GF Value™ is ₹4,321.64, compared to a current price of ₹4,768.30 — trading 10.3% above its estimated fair value. The current Construction In Progress is ₹4,856 Mil. Torrent Pharmaceuticals' overall GF Score™ is 85/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Construction In Progress calculated?
Construction In Progress is calculated from a company's financial statements. For Torrent Pharmaceuticals (NSE:TORNTPHARM), the current Construction In Progress is ₹4,856 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Torrent Pharmaceuticals (NSE:TORNTPHARM) Overvalued in 2026?

Based on GuruFocus' analysis, Torrent Pharmaceuticals stock appears to be overvalued. The current stock price of ₹4,768.30 is trading 10.3% above its estimated GF Value™ of ₹4,321.64. GuruFocus considers Torrent Pharmaceuticals to be Fairly Valued.

Key valuation signals for NSE:TORNTPHARM:

  • Construction In Progress: ₹4,856 Mil
  • GF Value™: ₹4,321.64 vs. price of ₹4,768.30 (10.3% above fair value)
  • GF Score™: 85/100 with 6 warning signs

No single metric tells the full story. See the NSE:TORNTPHARM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Torrent Pharmaceuticals Business Description

Other Exchanges 500420:India
Address Off Ashram Road, Torrent House, Ahmedabad, GJ, IND, 380009
Torrent Pharmaceuticals Ltd is a drug manufacturing company with a focus on the cardiovascular, central nervous system, Vitamins Minerals Nutrients (VMN), and gastrointestinal therapeutic areas. It operates through the Generic Formulation Business segment. Geographically, the business activities are carried out across Indian and International markets. Maximum revenue for the company is generated from its operations in India.
85GF Score

Get the complete analysis for NSE:TORNTPHARM

Construction In Progress is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹4,768.30
Price
₹4,321.64
GF Value